Curanex Pharmaceuticals Common Stock
CURX | NASDAQ
$5.29
+$0.35 (+7.09%)
At close: Oct 30, 2026, 3:59 PM ET
$5.10
-$0.19 (-3.63%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 2.94M | 4.02M | 4.97M | 5.83M | 108.86K | 198.94K | 148.89K | 244.32K | 374.26K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.85M | 4.08M | 6.25M | 8.59M | 596.19K | 490.79K | 367.87K | 327.13K | 292.13K |
Total Current Assets | 4.79M | 8.09M | 11.23M | 14.42M | 711.34K | 696.07K | 517.94K | 571.45K | 666.39K |
Property-Plant & Equipment | 280.94K | 317.57K | 352.62K | 60.4K | 75.84K | 90.87K | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 74.68K | 49.44K |
Total Long-Term Assets | 280.94K | 317.57K | 352.62K | 60.4K | 75.84K | 90.87K | n/a | 74.68K | 49.44K |
Total Assets | 5.07M | 8.41M | 11.58M | 14.48M | 787.17K | 786.94K | 517.94K | 646.12K | 715.83K |
Account Payables | 154 | 8.4K | 2.43K | 114.49K | 269 | 126.06K | 5K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 94.41K | n/a | n/a | n/a | 70.64K | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.6K | -600 |
Total Current Liabilities | 104.31K | 128.73K | 137.03K | 185.96K | 75.93K | 192.61K | 14.58K | 5.6K | 600 |
Long-Term Debt | 181.95K | n/a | 224.01K | n/a | 400K | 200K | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 181.95K | 203.91K | 224.01K | n/a | 405.82K | 228.56K | n/a | n/a | n/a |
Total Liabilities | 286.25K | 332.64K | 361.04K | 185.96K | 481.74K | 421.16K | 14.58K | 5.6K | 601 |
Total Debt | 276.36K | 311K | 346.7K | 61.15K | 476.45K | 291.18K | n/a | n/a | n/a |
Book Value | 4.79M | 8.08M | 11.22M | 14.29M | 305.43K | 365.78K | 503.36K | 640.52K | 715.23K |
Book Value Per Share | 3.38 | 5.70 | 7.92 | 10.09 | 0.22 | 0.26 | 0.36 | 0.46 | 0.52 |
Common Stock | 2.84K | 2.84K | 2.83K | 2.83K | 2.4K | 2.4K | 2.4K | 4K | 4K |
Retained Earnings | -11.29M | -8M | -4.85M | -1.77M | -820.38K | -760.03K | -622.45K | -485.29K | -385.35K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 4.79M | 8.08M | 11.22M | 14.29M | 305.43K | 365.78K | 503.36K | 640.52K | 715.23K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CURX